A small family business with large holdings

How promising companies
become successful.
Schörling’s role as an active owner is to create opportunities for companies to develop and become best in class. We believe in a long-term perspective, being cost-conscious, and building close relationships. And last, but not least, we believe in having focus on results.
Read More
AAK
Absolent
Anticimex
Assa Abloy
Greenbridge
Hexagon
Hexpol
Nibe
Securitas
Our Holdings

The companies we invest in

Schörling is an active owner specializing in industrial businesses with roots in Scandinavia. These companies are globally widespread and most of their sales take place outside of Sweden. They all share two similarities: great development potential from the beginning, and growth over time into world leaders in their respective niches.
Our Holdings

The relationships we build

About Us

To Schörling, people are and have always been the most important factor. In our team, our network and the companies we invest in. We surround ourselves with individuals with different competencies, experiences and personalities. Together, we share the same values and are driven by our ambition to develop sound businesses that become best in class. The Schörling board consists of a group of carefully selected people who all contribute with their substantial and diverse experience. They know our companies inside out.

About Us

The Schörling Foundation

The Schörling Foundation was instituted by the Schörling family in 2014. The Foundation is run without profit and has its financial base in a donation made by Melker Schörling, the founder of the company.

The Foundation’s purpose is to promote scientific education and research. This is done by supporting current and urgent projects run by institutes or individual researchers. In addition, the Foundation supports projects, organizations and individuals who encourage the development of children and young people.

"The Swedish FTD Initiative" is a research project founded and supported by the Foundation. The goal is to strengthen the collaboration within research so that one day effective treatment against FTD (frontotemporal dementia) will be offered. Two professors from Karolinska Institutet and two professors from KTH have together had the opportunity to build a consortium for research on the disease over several years.

In the beginning of 2022, The Schörling Foundation decided to grant funding to Karolinska Institutet, Department of Molecular Medicine and Surgery, Research Group Thoracic Surgery. The purpose of the donation is to enforce the devlopment of cardiothoracic surgical technology and methodology and the related reserach by the group.
Since 2014

News & Reports

Stay Updated
All News & Reports

Annual General Meeting of HEXPOL AB

Hexpol
 — 
2024
.
04
.
26
At today’s Annual General Meeting (AGM) of HEXPOL AB (publ), the following was resolved. Board of Directors, auditor and fees The number of directors will be seven. The meeting re-elected Alf Göransson, Jan‑Anders E. Månson, Malin Persson, Kerstin Lindell, Märta Schörling Andreen, Nils-Johan Andersson and Henrik Elmin, as ordinary Board Members. Alf Göransson was re-elected Chairman of the Board. The fees to the Board of Directors shall amount to a total of SEK 4,875,000 (including fees for committee work). The meeting re-elected the authorised public accountants Joakim Falck and
Read more →

Interim report January - March 2024

Hexpol
 — 
2024
.
04
.
26
JANUARY – MARCH 2024 · Sales amounted to 5,312 MSEK (5,990). · EBIT amounted to 905 MSEK (946). · EBIT-margin increased to 17.0 percent (15.8). · Profit after tax amounted to 654 MSEK (668). · Earnings per share amounted to 1.90 SEK (1.94). · Operating cash flow amounted to 112 MSEK (593). “We deliver a first quarter in 2024 with good profitability and high margins. In the quarter, sales amounted to 5,312 MSEK (5,990) and EBIT amounted to 905 MSEK (946). At the same time we strengthened the EBIT margin to 17.0 percent (15.8) driven by better product and price mix and
Read more →

Hexagon Interim Report 1 January - 31 March 2024

Hexagon
 — 
2024
.
04
.
26
First quarter 2024 • 3 per cent organic revenue growth (using fixed exchange rates and a comparable group structure) • Net sales increased by 1 per cent to 1,299.9 MEUR (1,286.6) • Net sales including the reduction of acquired deferred revenue amounted to 1,299.9 MEUR (1,285.1) • Adjusted gross margin of 66.5 per cent (66.5) • Adjusted operating earnings (EBIT1) increased by 1 per cent to 376.5 MEUR (371.2) • Adjusted operating margin amounted to 29.0 per cent (28.9) • Earnings per share, excluding adjustments, amounted to 10.1 Euro cent (10.4) • Earnings per share, including
Read more →
SV | EN
Birger Jarlsgatan 13
|
111 45 Stockholm
|
|